Skip to content

Author

Ming-Ze Lu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Nanozyme-Powered Immunotherapy via Concurrent Niche Disruption and Checkpoint Blockade for Acute Myeloid Leukemia.

Acute myeloid leukemia (AML) relapse and drug resistance remain major causes of mortality in hematologic malignancies, driven in part by CXCR4/CXCL12-mediated homing and retention of leukemic cells within the bone marrow niche, as well as immune evasion mechanisms that enable their persistent survival. Here, we report...

Fei Wang, Qian-Qian Li, Yan Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.